| |
FDA Approval Activities for this Drug
Banan (cefpodoxime proxetil) Tablets and Suspension Sankyo Pharma NDA: 50-687/SE8-004, SE1-007, SE2-010, SE2-011
NDA: 50-688/SE8-006, SE1-008, SE2-011, SE2-012 Cefpodoxime Proxetil Tablets, Ranbaxy Limited ANDA 65-083 8/20/03
Cefpodoxime Proxetil Powder Suspension, Ranbaxy Limited ANDA 65-082 Vantin (cefpodoxime proxetil) Suspension, 5 mg/kg Pharmacia & Upjohn NDA 50-675/S-014 11/20/98 11/20/98 8/1/01
Vantin (cefpodoxime proxetil) Tablets and Vantin® (cefpodoxime proxetil) Suspension. Pharmacia & Upjohn NDA 50-674/S-012
50-675/S-015 CEFPODOXIME PROXETIL For Suspension; 100MG BASE/5ML VANTIN PHARMACIA AND UPJOHN
050675 CEFPODOXIME PROXETIL For Suspension; 50MG BASE/5ML VANTIN PHARMACIA AND UPJOHN
065082 CEFPODOXIME PROXETIL For Suspension; 100MG BASE/5ML CEFPODOXIME PROXETIL Ranbaxy
065082 CEFPODOXIME PROXETIL For Suspension; 50MG BASE/5ML CEFPODOXIME PROXETIL Ranbaxy
050674 CEFPODOXIME PROXETIL Tablet; 100MG BASE VANTIN PHARMACIA AND UPJOHN
050674 CEFPODOXIME PROXETIL Tablet; 200MG BASE VANTIN PHARMACIA AND UPJOHN
065083 CEFPODOXIME PROXETIL Tablet; 100MG BASE CEFPODOXIME PROXETIL Ranbaxy
065083 CEFPODOXIME PROXETIL Tablet; 200MG BASE CEFPODOXIME PROXETIL Ranbaxy Vantin (cefpodoxime proxetil) Oral Suspension, Pharmacia & Upjohn Vantin (cefpodoxime proxetil) Tablets, Pharmacia & Upjohn
For the latest approval information, please see the main page.
|